AIRNA Partners with C-Path’s Alpha-1 Antitrypsin Deficiency Consortium to Propel Novel AATD Therapies
In a groundbreaking development within the realm of genetic medicine, Critical Path Institute’s (C-Path) Critical Path for Alpha-1 Antitrypsin Deficiency ...
